MIZOLASTINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C24H25FN6O
Molecular Weight	432.4933
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of MIZOLASTINE

Structure Search

SMILES

CN(C1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5

InChI

InChIKey=PVLJETXTTWAYEW-UHFFFAOYSA-N

InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32)

HIDE SMILES / InChI

Molecular Formula	C24H25FN6O
Molecular Weight	432.4933
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 18:00:42 UTC 2023` Edited by `admin` on `Sat Dec 16 18:00:42 UTC 2023`
Record UNII	244O1F90NA
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MIZOLASTINE

Official Name

English

MIZOLLEN

Brand Name

English

mizolastine [INN]

Common Name

English

MIZOLASTINE [MI]

Common Name

English

MIZOLASTINE [MART.]

Common Name

English

2-((1-(1-(P-FLUOROBENZYL)-2-BENZIMIDAZOLYL)-4-PIPERIDYL)METHYLAMINO)-4(3H)-PYRIMIDINONE

Common Name

English

Mizolastine [WHO-DD]

Common Name

English

MIZOLASTINE [JAN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29578

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

WHO-ATC

R06AX25

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

WHO-VATC

QR06AX25

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

Code System Code Type Description

EVMPD

SUB09018MIG

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

DRUG BANK

DB12523

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

FDA UNII

244O1F90NA

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

MERCK INDEX

m7577

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

Merck Index

NCI_THESAURUS

C66171

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

CAS

108612-45-9

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

DRUG CENTRAL

1824

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

PUBCHEM

65906

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

WIKIPEDIA

MIZOLASTINE

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

ChEMBL

CHEMBL94454

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

SMS_ID

100000080903

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

EPA CompTox

DTXSID5046801

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

RXCUI

61455

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

RxNorm

INN

6663

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

MESH

C076170

Created by admin on Sat Dec 16 18:00:42 UTC 2023 , Edited by admin on Sat Dec 16 18:00:42 UTC 2023

PRIMARY

Related Record Type Details


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND


					28XBT591QG

HISTAMINE H1 RECEPTOR

TARGET -> INHIBITOR

Qualification:

Kd

Amount:

Related Record Type Details


					244O1F90NA

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC